U.S., Nov. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07253259) titled 'A Clinical Study Evaluating the Safety and Efficacy of GT729 Universal Cell Injection in the Treatment of Refractory or Relapsed Chronic Graft-versus-host Disease (cGVHD)' on Nov. 19.
Brief Summary: The goal of this clinical study is to evaluate the safety and efficacy of GT729 universal cell injection in the treatment of refractory or relapsed chronic graft-versus-host disease (cGVHD).
Study Start Date: Dec., 2025
Study Type: INTERVENTIONAL
Condition:
cGVHD
Intervention:
BIOLOGICAL: GT729 Injection
GT729 Injection
Recruitment Status: RECRUITING
Sponsor: Grit Biotechnology
Published by HT Digital Content Services with perm...